scholarly journals Pyometra in the postpartum: a forgotten complication

Author(s):  
Rana A. Choudhary ◽  
Kedar N. Ganla ◽  
Kavita N. Desai ◽  
Priyanka H. Vora

We report a case of 37 years old women who conceived after in vitro fertilization (IVF). Her antenatal course was uneventful. On delivery there was placenta acreta. She later presented in the postpartum period with pyometra. She was managed with conservative treatment. We believe that the placental bed sutures and the sloughing placenta could have led to sterile pyometra in this patient. This rare but important complication need to be kept in mind specially in high risk women with thin endometrium, h/o IVF, cervical encerclage, and placenta acreta.

2006 ◽  
Vol 195 (3) ◽  
pp. 814-817 ◽  
Author(s):  
Stephen T. Chasen ◽  
Guoyang Luo ◽  
Sriram C. Perni ◽  
Robin B. Kalish

GYNECOLOGY ◽  
2020 ◽  
Vol 22 (6) ◽  
pp. 90-92
Author(s):  
Evgeny S. Mikhaylin ◽  
Lada A. Ivanova ◽  
Mariya M. Shilo ◽  
Igor V. Berlev

The article presents a personal observation of the course of pregnancy and childbirth in a patient with a typical form of gonadal dysgenesis (ShereshevskyTurner syndrome, karyotype 45,X0/46,XY in the ratio of clones 1:1). The diagnosis was established at 12 years of age during an examination for growth retardation and lack of signs of puberty. Given the presence of a 46,XY clone in the karyotype, a high risk of malignization of dysgenetic gonads, laparoscopy and gonadectomy were performed at 12 years of age. Pregnancy occurred after preparation of the endometrium with estrogens and progestogens, as a result of the first in vitro fertilization attempt with a donor egg and her husbands sperm, occurred against the background of hormonal support with the threat of termination of pregnancy and hypercoagulation. At 34 weeks, there was a premature detachment of placenta, in connection with which she was delivered by cesarean section.


PEDIATRICS ◽  
1979 ◽  
Vol 64 (1) ◽  
pp. 120-120
Author(s):  
William J. Turtle

So much time and money, research and expertise, sophisticated equipment and team effort go into seeing to it that the newborn leaves the hospital normal and healthy! In the midst of this remarkable scientific and technological progress, however, I wonder if something of far-reaching importance isn't being overlooked? Every baby, whether it's—full term normal—high risk—the product of artificial insemination, in vitro fertilization, or some future-day product of in vitro procreation —every baby has to go home, and I find myself asking! to what? As far as I can see, no comparable effort, study, or even interest is going into making sure that something remotely approaching this highly intensive level of care will be maintained in the home.


Sign in / Sign up

Export Citation Format

Share Document